Skip to Main

Torben Danger is the global leader for Boston Consulting Group's Health Care practice, which encompasses biopharma, medical technologies, payers, providers, health systems, and global health.

Since joining BCG in 2005, Torben has centered his client work on strategy, sales and marketing, integration, transformation, and operations projects in the medical technology and biopharma industries.

Through his assignments across many health care segments and locations, Torben has developed a firsthand appreciation of how cost pressure, provider consolidation, and other trends such as digitization affect the industry.

AREAS OF EXPERTISE

EDUCATION

  • PhD, law, University of Freiburg
  • MA, law, University of Freiburg

Publications and Videos

Bold Advances in Healthcare

Biogen’s CFO on Leading a People-First Transformation

Mike McDonnell explains how the global biotech is charting new paths to patientsvia Fit for Growth, its corporate transformation initiative.

The Three Responsibilities of Management

Biogen CFO Mike McDonnell on the leadership lessons he learned from his roles across different industries.

CEO Paul Hudson on Sanofi’s Bold New Strategy and “Snackable AI”

AI is playing a role in facilitating innovation in drug discovery and development at one of the world’s largest biopharmaceutical companies.

Bold Advances in Healthcare

CEO Julie Gerberding on How FNIH Promotes Public-Private Partnerships

The leader of the Foundation for the National Institutes of Health discusses how to build bridges to health care innovations.

Three Indispensable Leadership Lessons

FNIH CEO Julie Geberding explains what she's learned from her experience in academia, industry, and the public sector.

Building Breakthroughs in Gene Therapy Development

The Bespoke Gene Therapy Consortium, a public-private partnership led by the FNIH, has produced a protocol for streamlining development time significantly.

Bold Advances in Healthcare

Pfizer’s Lidia Fonseca on All Things Digital

Talking with Pfizer’s chief digital and technology officer about the extraordinary changes AI and other digital technologies are bringing to the health care industry.

Nurturing Digital Diversity, Equity, and Inclusion

Lidia Fonseca, Chief Digital and Technology Officer, on how Pfizer is helping women and other underrepresented groups enter STEM fields and navigate their careers.

Pfizer’s Digital Transformation

Chief Digital and Technology Officer Lidia Fonseca explains how Pfizer is leveraging digital and data across the value chain and the biggest wins so far.

Bold Advances in Healthcare

Innovating for a Healthier Future with Sanofi's CEO

BCG experts interview one of the world’s largest biopharmaceutical companies to discuss their bold “Play to Win” strategy and the role of AI in innovation.

CEO Paul Hudson on Sanofi’s Climate Ambition

Hudson discusses the company’s commitment to reaching net zero emissions by 2045.

CEO Paul Hudson on Sanofi’s Play for mRNA

Hudson discusses the company’s new mRNA Center of Excellence.